Cargando…
Amaryllidaceae alkaloids with anti-Trypanosoma cruzi activity
BACKGROUND: Chagas disease, caused by the protozoan Trypanosoma cruzi, is a neglected disease that affects ~7 million people worldwide. Development of new drugs to treat the infection remains a priority since those currently available have frequent side effects and limited efficacy at the chronic st...
Autores principales: | Martinez-Peinado, Nieves, Cortes-Serra, Nuria, Torras-Claveria, Laura, Pinazo, Maria-Jesus, Gascon, Joaquim, Bastida, Jaume, Alonso-Padilla, Julio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288428/ https://www.ncbi.nlm.nih.gov/pubmed/32522289 http://dx.doi.org/10.1186/s13071-020-04171-6 |
Ejemplares similares
-
Amaryllidaceae plants: a potential natural resource for the treatment of Chagas disease
por: Martínez-Peinado, Nieves, et al.
Publicado: (2021) -
Anti-Trypanosoma cruzi Activity of Metabolism Modifier Compounds
por: Martinez-Peinado, Nieves, et al.
Publicado: (2021) -
The Use of AlphaFold for In Silico Exploration of Drug Targets in the Parasite Trypanosoma cruzi
por: Ros-Lucas, Albert, et al.
Publicado: (2022) -
Identification of Trypanosoma cruzi Growth Inhibitors with Activity In Vivo within a Collection of Licensed Drugs
por: Martinez-Peinado, Nieves, et al.
Publicado: (2021) -
N-oxide alkaloids from Crinum amabile (Amaryllidaceae)
por: Tallini, Luciana R., et al.
Publicado: (2018)